The University of Texas Health Science Center at San Antonio is developing the new Sam and Ann Barshop Center for Longevity and Aging Studies. The Barshops donated $4 million to the Texas Research Park facility, which will provide laboratory space for scientists.
Qiagen Sciences is completing a 190,000-sf facility in Germantown, where the company is licensed to manufacture products resulting from the collaboration of Seattle-based Qiagen Genomics and The Institute for Genomic Research in Rockville, Md., on tuberculosis strains. Qiagen Genomics' parent company is Germany-based Qiagen.
The Boston Regional Medical Center is slated to be redeveloped into the Stoneham Executive Center, an R&D park with office, medical and biotechnology facilities. The $50 million project proposed by the Gutierrez Co. would include modifications to the existing developed 40.7-acre site and construction of 540,000 sf of space in three new office buildings, to be completed around August of 2002.
The State of California Department of General Services is working with Pleasanton, Calif.-based Neilsen Dillingham Builders to construct phases I & II of its new Richmond Laboratory Dept. of Health Services. The $115.2 million, 482,000-sf project includes a custom 326,000-sf, seven-building investigation facility, and a multi-building 156,000-sf research and testing facility. Begun in August, 1998, completion is anticipated by project manager NBBJ in November of 2001.
G.E. Medical Systems has a 283,500-sf, $40-million expansion under way at its Waukesha complex. A $30-million, three-story addition to the corporate headquarters building will provide 213,000 sf of office and manufacturing space. Completion is anticipated in December 2001. The magnetic resonance building is undergoing a 69,500-sf, $10-million addition that will add two stories to the facility, which houses R&D and manufacturing operations. A manufacturing cleanroom will also be part of the expansion. General contractor for the project is M.A. Mortenson.
J. David Gladstone Institutes, a nonprofit medical research center based in San Francisco, plans to expand at Mission Bay with a 180,000-sf biotech research park. The Institutes, whose operations are currently scattered in offices and labs at the campus of the University of California San Francisco, plans to increase its staff of researchers from 260 to 520 by the end of 2010. The new facility will cost $100 million, including the cost of the approximately five-acre site the Institutes plans to purchase. NBBJ Architects is designing the building.
Covance Laboratories will relocate its immunochemistry group from Vienna, Va., to a new laboratory under development at the Avion Tech Center III Park in Chantilly. Developer of the project is Biotech Services Group, the subsidiary of Scheer Partners that focuses on life science and biotech facilities. The new building will provide R&D labs and walk-in cold rooms in a 24,000-sf single-story structure.
Associates of Cape Cod Inc. (ACCI) is building a new 79,000-sf FDA-validated production facility for diagnostics in the Falmouth Technology Park. ACCI manufactures endotoxin diagnostic assays extracted from the blood of horseshoe crabs. Laboratories will feature state-of-the-art technology. The cleanroom production areas include Class 100 formulation and filling suites, accessible through airlocks. The production process and facilities will be fully validated in accordance with FDA cGMP requirements.
The Technology Commercialization Center, a $12-million project of the Illinois Medical District Commission, has been awarded to Knight Advanced Technology, the architecture/engineering subsidiary of Lester B. Knight & Associates. The 62,000-sf Center is envisioned as a “graduate” laboratory facility for biotechnology and other technology-based start-up companies that have outgrown an incubator laboratory setting. The project will be built at Chicago Technology Park.
The Howard Hughes Medical Institute has plans for a $500-million biomedical R&D complex at Janelia Farm in Ashburn. Bioinformatics, biomedical imaging, and gene protein research will be conducted at the facility, which will accommodate more than 300 scientists and support staff. Dormitories will provide accommodations for visiting researchers. Construction at the 281-acre site is scheduled to begin in 2003; completion is scheduled for late 2005.
Immunex Corporation broke ground in January 2001 on the Helix Project—a new $750-million research and technology center—on a 29-acre parcel of undeveloped industrial land in Seattle. The facility will consolidate Immunex’s Seattle employees and will accommodate approximately 1,700 employees. Phase I of the center totals 1.1 million gsf and is scheduled for completion in fall/winter 2003.
Lawrence Berkeley National Laboratory's Oakland Scientific Facility expected to take delivery of a $33 million IBM supercomputer in December 2000. The Oakland facility, a 75,000-sf former Wells Fargo Bank building, has undergone an $11 million retrofit including a new glass facade, seismic upgrades, a new cooling system, and special security devices. The computers will occupy rows of refrigerator-size cabinets that fill the building's first two floors. The project has been developed by Encinal Broadway, headed by Peter Wang.
Genentech plans to double its R&D space with three new buildings at the company’s South San Francisco campus. Construction is scheduled to begin in spring 2001 on the 288,744-sf project, which will create a total of nearly 600,000 sf for research at the site. Genentech has several other construction projects under way or planned: a 60,000-sf building opening in March, with an accompanying 500-vehicle parking garage opening in May; 120,000-sf of office space at Building 6, which broke ground in late January; and a just-completed 112,000-sf office building.
The Centers for Disease Control and Prevention (CDC) of Atlanta recently selected McCarthy of St. Louis to construct its $132-million Building 18, the Emerging Infections Diseases Laboratory. Construction is scheduled to begin in September 2001 at the CDC’s Roybal Campus. The new lab will provide approximately 310,500 gsf of space for 459 scientific personnel, and will be completed in two phases. Phase I, a six-story, 40,000-gsf structure, will provide dry lab space for 184 lab staff.
The U.S. Department of Health and Human Services' Food and Drug Administration (FDA) consolidated headquarters and laboratory campus broke ground recently at White Oak, a base realignment and closure site formerly home to the Naval Laboratory campus. The FDA, currently housed in more than 40 buildings at 18 different locations in the Washington, D.C., region will use 130 acres of the 670-acre campus.
